New research reveals that patients who come off new slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who end traditional lifestyle plans.
Research printed in a leading medical journal points out that while overweight individuals often shed substantial amounts of their body weight while using the jabs, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"Users purchasing these medications need to be aware of the potential of rapid rebound weight gain when the therapy is stopped," cautioned lead investigator Dr. Susan Jebb.
That rate of regain implies a return to pre-treatment weight within about 18 months.
Analyzing Treatments
The analysis, which examined dozens of trials involving thousands of participants, compared the effects of these new drugs with other pills.
The team emphasize that people who shed pounds through lifestyle changes alone usually have a more gradual creep back—approximately 100 grams monthly—after stopping.
Understanding the Quick Rebound
Experts propose the mechanism of the jabs is key to understanding the amplified weight return.
These medications imitate a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Long-term administration of the hormone levels several times higher than the body's typical production might result in the system to produce less of its endogenous hormone, and may also lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics specialist.
"Stopping of this hormone supplement leads to appetite is unsuppressed, making binge eating far more likely."
An Ongoing Condition?
Health authorities advise the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
Professionals argue that, considering the likelihood of relapse, the therapy is often life-long.
This opinion is supported by drug manufacturers, who say that the findings "emphasize the persistent nature of excess weight," comparing it to managing conditions like high blood pressure.
User Testimonies
Users who have discontinued the jabs report a sudden return of appetite.
"It felt as if a trigger that goes on and you become starving," said an individual.
The struggle is worsened if individuals have not established permanent dietary or behavioural changes during therapy.
Significant Use
Recent estimates suggest that a significant number of adults in the UK have tried these injections in the past year, with desire being substantial.
- Use is greater among females compared to males.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion access the drugs through private healthcare rather than public health services.
In conclusion, experts emphasize that while GLP-1 drugs are powerful agents for shedding pounds, they are not a standalone solution and long-term success likely depends on integrated behavioural management.
